Navigation Links
Novartis Group calls on FDA to maintain the well-established naming policy for all biologics to help ensure patient safety
Date:10/30/2013

BASEL, Switzerland, Oct. 30, 2013 /PRNewswire/ -- Novartis announced today it has filed a Citizen Petition with the U.S. Food and Drug Administration (FDA), urging the Agency to require that a biosimilar share the same INN as the reference product.

Novartis argues that changing the well-established convention that the INN describes the active ingredient would undermine the safe and rational use of all biologics. In its petition, the company also highlights that "assigning different INNs to biosimilars would introduce unnecessary confusion into the healthcare system and could unintentionally communicate increased caution, unfounded risk, or other regulatory reservations that are purely hypothetical."

The main points addressed in the Novartis Citizen Petition include:

  • INNs are not designed to identify a specific product or track adverse events. INNs were designed to indicate active pharmaceutical substances, not a specific product. They were also never intended to identify or track individual products; there is already a robust drug safety system in place – to report adverse events – for tracking and tracing.  The current system identifies each biologic by brand names, National Drug Code (NDC) numbers and manufacturer.
  • Changing the naming convention would undermine FDA's years of practice in reviewing and approving manufacturing changes of originator biologics without requiring new INNs. Requiring separate INNs for biosimilars but not originator biologics would undermine FDA's own approval decisions, which in both cases require FDA to determine that the compared product produces the same effect as its comparator.
  • An inconsistent application of naming conventions would lead to medication errors and jeopardize patient safety. Unique INNs for biosimilars would lead to confusion and encourage prescribing by INN. Current prescribing is by brand names with e
    '/>"/>

  • SOURCE Novartis
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Novartis begins shipment of seasonal influenza vaccines to US market
    2. Novartiss Serelaxin Has the Potential to Fulfill the Most Pertinent Unmet Needs in Acute Heart Failure by Reducing the Rate of Patient Mortality and the Rate of Worsening Renal Function
    3. Novartis Breakthrough Therapy LDK378 shows a marked clinical response in patients with ALK+ non-small cell lung cancer
    4. Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts
    5. Novartis signs on to support Malaria No Mores Power of One campaign to stride towards a future without malaria
    6. Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy
    7. Novartis Pharma Logistics, Inc. voluntarily recalling in Jamaica select lots of certain over-the-counter products due to bottle closure defect
    8. Novartis Pharma Logistics, Inc. voluntarily recalling in Trinidad & Tobago select lots of certain over-the-counter products due to bottle closure defect
    9. Novartis Pharma Logistics, Inc. voluntarily recalling in Curacao select lots of certain over-the-counter products due to bottle closure defect
    10. Novartis Pharma Logistics, Inc. voluntarily recalling in Aruba select lots of certain over-the-counter products due to bottle closure defect
    11. Novartis Pharma Logistics, Inc. voluntarily recalling in Barbados select lots of certain over-the-counter products due to bottle closure defect
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/3/2015)... -- Encision Inc. (PK:ECIA), a medical device company owning patented ... minimally invasive surgery, today announced financial results for its ... The Company posted quarterly net revenue of ... thousand, or $(0.02) per share. These results compare to ... of $202 thousand, or $(0.02) per share, in the ...
    (Date:8/3/2015)... 2015  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ; ... exclusive licensing agreement to develop and commercialize multiple prespecified ... a holding company for premier antibody development and manufacturing ... Under the terms of the agreement, Sorrento will ... the North American, European and Japanese market. Each of ...
    (Date:8/2/2015)... Aug. 3, 2015  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... TELESTAR Phase 3 clinical trial met its primary ... in treating cancer patients with carcinoid syndrome that ... of care. Telotristat etiprate was discovered using Lexicon,s ... is the company,s first discovery to complete a ...
    Breaking Medicine Technology:Encision Reports First Quarter Fiscal Year 2016 Results 2Encision Reports First Quarter Fiscal Year 2016 Results 3Encision Reports First Quarter Fiscal Year 2016 Results 4Encision Reports First Quarter Fiscal Year 2016 Results 5Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 2Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 3Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 4Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 2Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 3Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 4Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 5Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 6
    ... 9, 2012  The National Association of Drug ... facilitates cooperation between law enforcement, healthcare professionals, ... the prevention and investigation of drug diversion -- ... Log Exchange (NPLEx) in Kentucky is blocking ...
    ... MedPlast, Inc.,s ability to craft the pessary balloons ... the company,s commitment to premium quality output and complete ... Today,s pessaries are precision-manufactured medical devices that ... treat a variety of gynecologic conditions, including prolapse. In ...
    Cached Medicine Technology:Kentucky Real-Time, Stop-Sale System Is Effective In Blocking Illegal Sales Of Pseudoephedrine 2MedPlast's Pessary Balloon Manufacture Showcases Multi-Function Technical Mastery 2
    (Date:8/3/2015)... , ... August 03, 2015 , ... Dignity Health named ... Arizona General Hospital Emergency Room – Gilbert, opening in August. The new facility ... year in the West Valley. , “Dr. Baldwin is an excellent leader and ...
    (Date:8/3/2015)... ... August 03, 2015 , ... ... of medical information, risk management and investigative services, has introduced a new ... focused, expert information solutions that improve business outcomes for its customers. EMSI’s ...
    (Date:8/2/2015)... ... ... A new Phase I research study is looking at a vaccine that hopes ... G. Lucas, M.D. , chief of the division of pediatric hematology/oncology and stem cell ... Hospital and in the UofL Department of Pediatrics . Patients are currently ...
    (Date:8/1/2015)... ... 02, 2015 , ... Back packs can be dangerous? Whaaat?! , Not the ... wreck havoc on a kid's spine. With school starting again, most kids will be ... sure you are aware of how to help them prevent injuries by understanding backpack ...
    (Date:8/1/2015)... ... August 01, 2015 , ... Tina Wilcoxson, owner of Freeport Maine’s Royal ... that honor by the National Retail Federation, the largest retail trade association in the ... three Maine business owners to be named as such. According to the NRF’s website, ...
    Breaking Medicine News(10 mins):Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2Health News:UofL Physicians Conducting Vaccine Trial for Children with Relapsed Tumors at Kosair Children’s Hospital 2Health News:Local AlignLife Doctor Donates Time to Check Back Packs 2Health News:Local Retail Advocate Wins National Recognition 2
    ... Meet Isabel, a busy,active 50-year-old Hispanic woman who has ... son; and enjoys being a grandmother to her,daughter,s son. ... her wrist, and her doctor tells her she has ... is typical of many women like her. To ...
    ... Mobile Dental Clinic to Visit Delaware,Philadelphia, and Southern New Jersey ... to Area Children ... The St. Christopher,s,Foundation for Children Ronald McDonald Care Mobile ... Dental Hygiene Month,(October). The tour will include stops at the ...
    ... for Pulmonary Study, SOLANA BEACH, Calif., ... a firm specializing in patient recruitment for,clinical ... of Regional Recruitment,Specialists(TM) in support of recruiting ... Pulmonary Disease (COPD) for a recently initiated,clinical ...
    ... WASHINGTON, Oct. 1 House Republican Whip Roy,Blunt (Mo.) ... posturing and work with Republicans on crafting a real,meaningful ... to quality health care., "If Democrats are serious ... they,ll have to start working with House,Republicans to craft ...
    ... at ERS 17th Annual Congress -, REDWOOD ... announced the submission of a pre-market approval (PMA) ... requesting regulatory,approval to market the Emphasys endobronchial valve, ... EBV is a minimally invasive and potentially,reversible treatment ...
    ... Del., Oct. 1 More than 125 leaders,from ... Ann Minner, joined,together to support a multi-year, statewide ... Nation. The campaign, launched by Nemours Health,and Prevention ... of,schools, communities, health professionals, parents, and other leaders ...
    Cached Medicine News:Health News:Story Reveals How Isabel and Her Family Learn About Bone Health and Osteoporosis 2Health News:Story Reveals How Isabel and Her Family Learn About Bone Health and Osteoporosis 3Health News:St. Christopher's Foundation For Children Ronald McDonald(R) Care Mobile Making Tri-State Visits to Provide Dental Care to Children at No Cost 2Health News:RESolutions Rapid Enrollment Solutions, LLC Mobilizes Team of Regional Recruitment Specialists(TM) 2Health News:Emphasys Medical Announces PMA Submission for Bronchial Valve Therapy 2Health News:Emphasys Medical Announces PMA Submission for Bronchial Valve Therapy 3Health News:More than 125 State Leaders - Including Governor, Lt. Governor, and Congressional Delegation - Endorse Campaign to Make Delaware's Kids the Healthiest in the Nation 2Health News:More than 125 State Leaders - Including Governor, Lt. Governor, and Congressional Delegation - Endorse Campaign to Make Delaware's Kids the Healthiest in the Nation 3
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    Medicine Products: